A Randomized, Placebo-Controlled Trial Evaluating the Impact of a Synbiotic Dietary Supplement on Markers of Gastrointestinal Health
OvationLab
Summary
A 12-week, randomized, double-blind, placebo-controlled clinical trial will be conducted evaluating the effectiveness of Enviromedica - Terraflora Daily Care on markers of gastrointestinal function and symptoms.
Eligibility
- Age range
- 25+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: 1. Adult males or females age ≥ 25 years 2. Ability to read and speak English 3. Dysbiosis (≥3 on GA-Map Dysbiosis Score) on a stool test (GI360 Profile, Doctor's Data, St. Charles, Illinois) Exclusion Criteria: 1. Daily use within the past month of any probiotic or prebiotic supplement 2. Current diagnosis of inflammatory bowel disease, including Crohn's or ulcerative colitis 3. Current daily usage of non-steroidal anti-inflammatory drugs (NSAID), proton pump inhibitors (PPI), or antibiotic medications 4. Current daily tobacco smoker 5. Known allergies to any substance…
Interventions
- Dietary SupplementSynbiotic Dietary Supplement
12 weeks of supplementation with Enviromedica - Terraflora Daily Care
- Dietary SupplementPlacebo
Placebo capsule
Location
- OvationLabRichmond, Virginia